Founded in December 2005, Genocore Biotech is an innovation-driven biopharmaceutical company focused on development and commercialization of therapeutic monoclonal antibody (mAbs) and Fc-fusion protein drugs.
Genocore Biotech now has in place more than 6000 m2 of space, including R&D Lab, Process Development & Pilot Production Lab, Quality & Analytical Center, and a cGMP clinical production facility, all equipped with state of art equipment. A commercial-scale cGMP product facility is also under active planning.
Genocore Biotech is one of the world's pioneers in biotechnology, with a focus on developing therapies for neurodegenerative, hematologic and autoimmune ...
With a total investment of about 30 million USD, Genocore Biotech now has 10 products in the pipeline with three at the clinical trial/IND stage, about 110 ...
FOR COMPLETE REPORT, PLEASE VISIT (LINK)